Real Estate Credit Investments Analyst Q&A: Dividend yield is the highest of its immediate peers (LON:RECI) 27 May 2021
Cerillion Q&A: Larger telecom deals, managed services and long-term relationships key to recurring revenue growth (LON:CER) 25 May 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Real Estate Credit Investments Analyst Q&A: Dividend yield is the highest of its immediate peers (LON:RECI) 27 May 2021
Cerillion Q&A: Larger telecom deals, managed services and long-term relationships key to recurring revenue growth (LON:CER) 25 May 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 135% Potential Upside 15 December 2025
Masimo Corporation (MASI) Stock Analysis: Unlocking a Potential 32.82% Upside in the Healthcare Sector 15 December 2025
Glaukos Corporation (GKOS): Investor Outlook and Key Metrics Highlighting a Promising 11.98% Upside 15 December 2025
Humana Inc. (HUM) Investor Outlook: Exploring a 7.45% Potential Upside in Healthcare Plans 15 December 2025
Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Booming Biotech with 362% Revenue Growth 15 December 2025
Roivant Sciences (ROIV) Stock Analysis: A Promising Biotech with a 16% Upside Potential 15 December 2025
Stevanato Group S.p.A. (STVN) Investor Outlook: 37.56% Potential Upside Captures Attention 15 December 2025
BioNTech SE (BNTX) Stock Analysis: Navigating a 46.33% Potential Upside in the Biotechnology Sector 15 December 2025
Solventum Corporation (SOLV) Stock Analysis: Evaluating the 1.67% Potential Upside in Healthcare 15 December 2025
Hologic, Inc. (HOLX) Investor Outlook: Stability in Women’s Health Sector with Modest Upside 15 December 2025
CVS Health Corporation (CVS) Stock Analysis: Unpacking an 18% Upside Potential for Investors 15 December 2025
Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 21 Buy Ratings and a Promising Pipeline 15 December 2025
Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 55.64% Potential Upside in the Health Information Sector 15 December 2025
Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector 15 December 2025
Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Revenue Challenges 15 December 2025
Incyte Corporation (INCY): Analyst Ratings Highlight Growth Potential Amid Market Volatility 15 December 2025
Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 2.43% Potential Upside 15 December 2025
Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings 15 December 2025
Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Deep Dive into its 23.94% Potential Upside 15 December 2025
Cizzle Biotechnology MOU to take diagnostic capabilities into the therapeutic arena (Interview) 23 June 2021
Time Finance positive results and a plan to more than double the lending book (Interview) 21 June 2021
Glencore plc receives final regulatory approval for a 77% acquisition of Elk Valley Resources 5 July 2024
Real Estate Credit Investments Analyst Q&A: Dividend yield is the highest of its immediate peers (LON:RECI) 27 May 2021
Cerillion Q&A: Larger telecom deals, managed services and long-term relationships key to recurring revenue growth (LON:CER) 25 May 2021
Fidelity Special Values “Outstanding Performance” Beats Nasdaq Composite Index I Latest Research 15 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
